Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2025)
Eton Pharmaceuticals (ETON) reported Other financing activities of $204000.0 for Q4 2025, down 79.9% on a YoY basis from $1.0 million in Q4 2024, and down 48.22% sequentially from $394000.0 in Q1 2025.
Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Other financing activities data on file, last reported at $204000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities fell 79.9% year-over-year to $204000.0; the trailing twelve-month figure through Dec 2025 stood at $598000.0 (down 49.79% YoY), and the FY2025 full-year result was $598000.0, down 49.79% from the prior year.
- Other financing activities declined to $204000.0 in Q4 2025, from $394000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.0 million in Q4 2024 to a low of -$117000.0 in Q4 2022.
- A 5-year average of $162125.0 and a median of $110000.0 in 2021 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities plunged 272.06% in 2022 and soared 5528.57% in 2025, its largest moves.
- Tracing ETON's Other financing activities over 5 years: stood at $68000.0 in 2021, then sank by 272.06% to -$117000.0 in 2022, then soared by 49.57% to -$59000.0 in 2023, then surged by 1820.34% to $1.0 million in 2024, then tumbled by 79.9% to $204000.0 in 2025.
- Business Quant data shows ETON's Other financing activities at $204000.0 in Q4 2025, $394000.0 in Q1 2025, and $1.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 204,000.00 |
| Dec 31, 2025 | 204,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Jun 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 139,000.00 |
| Jun 30, 2023 | 139,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Dec 31, 2022 | -117,000.00 |
| Dec 31, 2022 | -117,000.00 |